IPSC-derived NK cells engineered with CD226 effectively control acute myeloid leukemia
Ontology highlight
ABSTRACT: iPSC-derived NK cells engineered with CD226 effectively control acute myeloid leukemia
PROVIDER: PRJNA1237813 | ENA |
REPOSITORIES: ENA
ACCESS DATA